This is a post about the international interest in
Delaware corporate law and the global impact of Delaware corporate law.
(Parenthetically, after six years of blogging at my former firm, this is my
first post on this blog as the head of the Wilmington office of the Eckert
Seamans firm. More details...
The current China hot button appears to be a series of
meetings between representatives of the Securities and Exchange Commission, the
Public Company Accounting Oversight Board, and their counterparts in China. The
hope is to convince the PRC government to allow the US regulators to inspect
We often hear about how China's
merger review "diverges" from other jurisdictions, most recently in
reaction to conditional approvals of the Seagate/Samsung and Western
Digital/Hitachi mergers. But China's MOFCOM is merely doing its homework.
Similar to "fusion"...
This past February the US
Department of Justice ("DOJ") and European Commission
("Commission") cleared Google Inc.'s acquisition of Motorola Mobility
Holdings Inc. without any conditions. In contrast, on May 19, 2012 the Chinese
Ministry of Commerce ("MOFCOM"...
A number of PRC based issuers have been named as defendants in SEC enforcement actions. These cases involve a range of issues including financial fraud, manipulation and misuse of assets.
Misrepresentations and financial fraud are the central allegations in SEC v. SinoTechEnergy...
This article was reprinted with permission
from FCPA Professor
A collection of recent China-related developments and
First, a recent U.S. Chamber of Commerce report titled
"China's Approval Process for Inbound Foreign Direct Investment" which details
a number of trade...
The China Institute of International Antitrust and
Investment (CIIAI) was established in March 2012 by the China University of
Political Science and Law, each of which is based in Beijing, with the goals of
promoting due process and transparency in antitrust proceedings, as well as the
NEW YORK- (Mealey's) A federal judge in New York on March
14 entered judgment for $153.3 million after trebling a jury's $54.1 million
verdict in favor of a direct purchaser class on its allegations that Chinese
corporations participated in an illegal cartel to fix prices and limit supply...
If you are in London this week, I might suggest that you drop by the British Film Institute (BFI), which is celebrating the work of the Indian film maker, Satyajit Ray. If you have never seen a Satyajit Ray film, all I can say is that you have missed one of the world’s greatest directors. In an...
This article was reprinted with permission from FCPA Professor
GlaxoSmithKline’s (GSK) scrutiny in China – by the Chinese government – dominated the headlines in July (see here for a prior post).
Shortly thereafter, many began to question the motivations of the Chinese government...
Cybersecurity has been a hot button issue for quite a while, but the U.S. Department of Justice ratcheted things up last week when it announced the indictment of five Chinese military officers for hacking into U.S. companies’ computers to steal trade secrets and other sensitive business information...
The GlaxoSmithKline PLC (GSK) corruption matter in China continues to reverberate throughout the international business community, inside and outside China. The more I think about the related trial of Peter Humphrey and his wife, Yu Yingzeng for violating China’s privacy laws regarding their investigation...
Marvin ‘Bad News’ Barnes died last week. Barnes probably summed up the state of professional basketball more than any one person in the 1970s. He was enigmatic, supremely talented, defiantly self-indulgent, fell prey to drugs and alcohol and lost everything. He exploded onto the national...
The year just completed was a banner year for IPOs in the U.S., with more companies completing their initial public offerings on U.S. exchanges in 2014 than in any year since 2000 (as detailed here ). But as I have previously noted ( here ), with an increase in IPO activity comes the likelihood of IPO...